The Effect of Viral Suppression on Cross-Sectional Incidence Testing in the Johns Hopkins Hospital Emergency DepartmentLAEYENDECKER, Oliver; ROTHMAN, Richard E; HENSON, Charlamaine et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 2, pp 211-215, issn 1525-4135, 5 p.Article

Behind the Cascade: Analyzing Spatial Patterns Along the HIV Care ContinuumEBERHART, Michael G; YEHIA, Baligh R; HILLIER, Amy et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 64, issn 1525-4135, S42-S51, SUP1Article

Poor retention in care one-year after viral suppression: a significant predictor of viral reboundCRAWFORD, Timothy N.AIDS Care (Print). 2014, Vol 26, Num 11-12, pp 1393-1399, issn 0954-0121, 7 p.Article

Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanismsLORI, Franco; FOLI, Andrea; GROFF, Antonella et al.AIDS (London). 2005, Vol 19, Num 11, pp 1173-1181, issn 0269-9370, 9 p.Article

Poor Baseline Immune Function Predicts an Incomplete Immune Response to Combination Antiretroviral Treatment Despite Sustained Viral SuppressionFALSTER, Kathleen; PETOUMENOS, Kathy; CHUAH, John et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 3, pp 307-313, issn 1525-4135, 7 p.Conference Paper

Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failuresBENZIE, Andrew A; BANSI, Loveleen K; ORKIN, Chloe et al.AIDS (London). 2007, Vol 21, Num 11, pp 1423-1430, issn 0269-9370, 8 p.Article

Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients : The Wwiss HIV cohort studyGLASS, Tracy R; DE GEEST, Sabina; BUCHER, Heiner C et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 41, Num 3, pp 385-392, issn 1525-4135, 8 p.Article

Hazardous alcohol use : A risk factor for non-adherence and lack of suppression in HIV infectionCHANDER, Geetanjali; LAU, Bryan; MOORE, Richard D et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 4, pp 411-417, issn 1525-4135, 7 p.Article

Social and Environmental Predictors of Plasma HIV RNA Rebound Among Injection Drug Users Treated With Antiretroviral TherapyMILLOY, M.-J; KERR, Thomas; BUXTON, Jane et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 4, pp 393-399, issn 1525-4135, 7 p.Article

Early and delayed benefits of HIV-1 suppression : timeline of recovery of innate immunity effector cellsAZZONI, Livio; CHEHIMI, Jihed; LAN ZHOU et al.AIDS (London). 2007, Vol 21, Num 3, pp 293-305, issn 0269-9370, 13 p.Article

HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug useCHANDER, Geetanjali; HIMELHOCH, Seth; FLEISHMAN, John A et al.AIDS Care (Print). 2009, Vol 21, Num 5, pp 655-663, issn 0954-0121, 9 p.Article

Adherence to Antiretrovirals Among US Women During and After PregnancyBARDEGUEZ, Arlene D; LINDSEY, Jane C; READ, Jennifer S et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 4, pp 408-417, issn 1525-4135, 10 p.Article

Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected childrenLARRU, Beatriz; RESINO, Salvador; ASENSI, Manuel et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 1, pp 183-190, issn 0305-7453, 8 p.Article

The link between CD8⁺ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolateLISSINA, Anna; FASTENACKELS, Solène; PRICE, David A et al.AIDS (London). 2014, Vol 28, Num 4, pp 477-486, issn 0269-9370, 10 p.Article

Achievement and Maintenance of Viral Suppression in Persons Newly Diagnosed With HIV, New York City, 2006―2009: Using Population Surveillance Data to Measure the Treatment Part of Test and TreatTORIAN, Lucia V; QIANG XIA.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 3, pp 379-386, issn 1525-4135, 8 p.Article

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine : the Swiss HIV Cohort StudyWOLBERS, Marcel; OPRAVIL, Milos; GÜNTHARD, Huldrych et al.AIDS (London). 2007, Vol 21, Num 16, pp 2201-2207, issn 0269-9370, 7 p.Article

Effect of CD4⁺ cell count and viral suppression on risk of ischemic stroke in HIV infectionCHOW, Felicia C; BACCHETTI, Peter; KIM, Anthony S et al.AIDS (London). 2014, Vol 28, Num 17, pp 2573-2577, issn 0269-9370, 5 p.Article

Linkage, Engagement, and Viral Suppression Rates Among HIV-Infected Persons Receiving Care at Medical Case Management Programs in Washington, DC : Linkage, Engagement and Viral Suppression Rates among HIV-Infected Persons Receiving Care at Medical Case Management Programs in Washington, DCWILLIS, Sarah; CASTEL, Amanda D; AHMED, Tashrik et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 64, issn 1525-4135, S33-S41, SUP1Conference Paper

CD4, Viral Load Response, and Adherence Among Antiretroviral-Naive Breast-feeding Women Receiving Triple Antiretroviral Prophylaxis for Prevention of Mother-to-Child Transmission of HIV in Kisumu, KenyaOKONJI, Jully A; ZEH, Clement; WEIDLE, Paul J et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 2, pp 249-257, issn 1525-4135, 9 p.Article

Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers : a proof-of-concept studyYANG, S.-H; LEE, C.-G; KHARCHENKO, N et al.Gene therapy (Basingstoke). 2006, Vol 13, Num 14, pp 1110-1117, issn 0969-7128, 8 p.Article

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral loadNEGREDO, Eugenia; MOLTO, José; GRASSI, Jacques et al.AIDS (London). 2004, Vol 18, Num 3, pp 459-463, issn 0269-9370, 5 p.Article

Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionPHILLIPS, Andrew N; LEDERGERBER, Bruno; HORBAN, Andrzej et al.AIDS (London). 2004, Vol 18, Num 13, pp 1795-1804, issn 0269-9370, 10 p.Article

Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responsesVANDEWOUDE, Site; HAGEMAN, Catherine L; HOOVER, Edward A et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, Num 1, pp 20-31, issn 1525-4135, 12 p.Article

High levels of adherence do not prevent accumulation of HIV drug resistance mutationsBANGSBERG, David R; CHARLEBOIS, Edwin D; MOSS, Andrew et al.AIDS (London). 2003, Vol 17, Num 13, pp 1925-1932, issn 0269-9370, 8 p.Article

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modificationPETERSEN, Maya L; VAN DER LAAN, Mark J; NAPRAVNIK, Sonia et al.AIDS (London). 2008, Vol 22, Num 16, pp 2097-2106, issn 0269-9370, 10 p.Article